Menzies D - Search Results

1

Correction: The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review.

Bastos ML, Menzies D, Hone T, Dehghani K, Trajman A. Bastos ML, et al. Among authors: menzies d. PLoS One. 2017 Dec 7;12(12):e0189557. doi: 10.1371/journal.pone.0189557. eCollection 2017. PLoS One. 2017. PMID: 29216304 Free PMC article.

2

Occupational respiratory infections.

Trajman A, Menzies D. Trajman A, et al. Among authors: menzies d. Curr Opin Pulm Med. 2010 May;16(3):226-34. doi: 10.1097/MCP.0b013e328338639b. Curr Opin Pulm Med. 2010. PMID: 20375784 Review.

3

Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.

Aspler A, Long R, Trajman A, Dion MJ, Khan K, Schwartzman K, Menzies D. Aspler A, et al. Among authors: menzies d. Thorax. 2010 Jul;65(7):582-7. doi: 10.1136/thx.2009.125054. Thorax. 2010. PMID: 20627913 Clinical Trial.

4

Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.

Steffen R, Menzies D, Oxlade O, Pinto M, de Castro AZ, Monteiro P, Trajman A. Steffen R, et al. Among authors: menzies d. PLoS One. 2010 Nov 17;5(11):e14014. doi: 10.1371/journal.pone.0014014. PLoS One. 2010. PMID: 21103344 Free PMC article.

5

How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.

Oxlade O, Pinto M, Trajman A, Menzies D. Oxlade O, et al. Among authors: menzies d. PLoS One. 2013;8(3):e56044. doi: 10.1371/journal.pone.0056044. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505412 Free PMC article. Review.

6

Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.

Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A. Steffen RE, et al. Among authors: menzies d. PLoS One. 2013 Apr 4;8(4):e59546. doi: 10.1371/journal.pone.0059546. Print 2013. PLoS One. 2013. PMID: 23593145 Free PMC article.

7

Reply to Wang and Zhang.

Bastos ML, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in Multidrug-Resistant Tuberculosis. Bastos ML, et al. Among authors: menzies d. Clin Infect Dis. 2015 Apr 15;60(8):1286-7. doi: 10.1093/cid/ciu1171. Epub 2014 Dec 30. Clin Infect Dis. 2015. PMID: 25552550 No abstract available.

8

Active tuberculosis case finding-do we have the right tool?

Trajman A, Menzies D. Trajman A, et al. Among authors: menzies d. Lancet Infect Dis. 2016 Sep;16(9):986-987. doi: 10.1016/S1473-3099(16)30133-5. Epub 2016 Jun 8. Lancet Infect Dis. 2016. PMID: 27289388 No abstract available.

9

Treatment of human disease due to Mycobacterium bovis: a systematic review.

Lan Z, Bastos M, Menzies D. Lan Z, et al. Among authors: menzies d. Eur Respir J. 2016 Nov;48(5):1500-1503. doi: 10.1183/13993003.00629-2016. Epub 2016 Aug 18. Eur Respir J. 2016. PMID: 27540021 Free article. Review. No abstract available.

10

An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis.

Bastos ML, Lan Z, Menzies D. Bastos ML, et al. Among authors: menzies d. Eur Respir J. 2017 Mar 22;49(3):1600803. doi: 10.1183/13993003.00803-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28331031 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

656 results

Search Page